Monte Rosa Therapeutics Inc (GLUE)

02:44 AM

Monte Rosa Therapeutics (NASDAQ:GLUE) Trading Up 6.9%Should You Buy? - MarketBeat

02:44 AM

Jul 06, 2026

Form 4 Monte Rosa Therapeutics Inc For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026

Jul 06, 2026

NEA funds shift 1,000,000 Monte Rosa shares (NASDAQ: GLUE) - Stock Titan

Jul 06, 2026

Jul 06, 2026

NEA adjusts Monte Rosa Therapeutics (GLUE) stake with share distribution and sales - Stock Titan

Jul 06, 2026

Jul 06, 2026

GLUEMonte Rosa Therapeutics Inc Volatility & Greeks - Finviz

Jul 06, 2026

Jul 05, 2026

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jul 05, 2026

Jul 02, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 02, 2026

Jul 01, 2026

Monte Rosa CMO Filip Janku sells $132k in company stock - Investing.com

Jul 01, 2026

Jul 01, 2026

Filip Janku Sells 5,407 Shares of Monte Rosa Therapeutics (NASDAQ:GLUE) Stock - MarketBeat

Jul 01, 2026

Jul 01, 2026

Form 4 Monte Rosa Therapeutics Inc For: 1 July By Investing.com - Investing.com India

Jul 01, 2026

Jul 01, 2026

Monte Rosa Therapeutics (NASDAQ: GLUE) CMO trades 5,407 shares under 10b5-1 plan - Stock Titan

Jul 01, 2026

Jun 30, 2026

Form 144 Monte Rosa Therapeutics For: 30 June By Investing.com - Investing.com Australia

Jun 30, 2026

Jun 30, 2026

Form 4 Monte Rosa Therapeutics Inc For: 30 June By Investing.com - Investing.com South Africa

Jun 30, 2026

Jun 30, 2026

Monte Rosa director Anthony Manning sells $231,100 in GLUE shares By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 30, 2026

GLUE (NASDAQ: GLUE) affiliate reports option exercise and 10b5-1 sales in June 2026 - Stock Titan

Jun 30, 2026

Jun 30, 2026

Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jun 30, 2026

Jun 30, 2026

Monte Rosa (NASDAQ: GLUE) CMO exercises options, sells 6,000 shares - Stock Titan

Jun 30, 2026

Jun 30, 2026

Monte Rosa (NASDAQ: GLUE) director exercises options, sells 10,000 shares at $23.11 - Stock Titan

Jun 30, 2026

Jun 30, 2026

Guggenheim raises Monte Rosa stock price target on pipeline potential - Investing.com UK

Jun 30, 2026

Jun 30, 2026

Guggenheim raises Monte Rosa stock price target on pipeline potential By Investing.com - Investing.com South Africa

Jun 30, 2026

Jun 29, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 29, 2026

Jun 29, 2026

After a 400% Surge, Should Investors Care About This $882,000 Monte Rosa Insider Sale? - The Motley Fool

Jun 29, 2026

Jun 29, 2026

GLUE (NASDAQ: GLUE) option exercise; insider 10b5-1 sales total 41,845 shares - Stock Titan

Jun 29, 2026

Jun 29, 2026

Anthony Manning sells 10,000 GLUE shares; option exercise planned (GLUE) - Stock Titan

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Does Monte Rosa Therapeutics' (GLUE) Shift Into Russell Growth Indices Recast Its Biotech Risk Profile? - simplywall.st

Jun 28, 2026

Jun 28, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Monte Rosa Therapeutics, Inc. Actuals & Estimates (NASDAQ:GLUE) - TradingView

Jun 26, 2026

Jun 25, 2026

Monte Rosa (GLUE) CMO sells 41,845 shares after exercising options - Stock Titan

Jun 25, 2026

Jun 25, 2026

Monte Rosa (NASDAQ: GLUE) COO exercises stock options, sells 2,175 shares - Stock Titan

Jun 25, 2026

Jun 25, 2026

GLUE Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Monte Rosa Therapeutics Inc (GLUE) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 25, 2026

Jun 24, 2026

Insider exercises 30,000 shares; sells 11,845 under 10b5-1 (GLUE) - Stock Titan

Jun 24, 2026

Jun 24, 2026

Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $29 - Moomoo

Jun 24, 2026

Jun 24, 2026

Monte Rosa Therapeutics Inc (GLUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026

Jun 24, 2026

Form 144 MONTE ROSA THERAPEUTICS INC For: 23 June By Investing.com - Investing.com South Africa

Jun 24, 2026

Jun 23, 2026

Form 144 MONTE ROSA THERAPEUTICS For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026

Jun 23, 2026

GLUE News | MONTE ROSA THERAPEUTICS INC (NASDAQ:GLUE) - ChartMill

Jun 23, 2026

Jun 23, 2026

Form 144 Monte Rosa Therapeutics For: 23 June By Investing.com - Investing.com Australia

Jun 23, 2026

Jun 23, 2026

GLUE (NASDAQ: GLUE) insider files Form 144 to sell 11,845 shares on 06/23/2026 - Stock Titan

Jun 23, 2026